CD8A and cancer: Briefly, CD8+ T cells from healthy human donors were transduced with a T cell receptor specific for the NY-ESO-1 cancer antigen, and the transgenic T cells were stimulated with NY-ESO-1 either acutely or repeatedly to induce full effector function (TEFF) or a hypofunctional state of exhaustion (TEX), respectively.